Acquired Angioedema Due to C1 inhibitor Deficiency Caused by Non-Hodgkin Lymphoma in a Patient with Myasthenia Gravis

1. Otani IM, Banerji A. Acquired C1 Inhibitor Deficiency. Immunol Allergy Clin North Am. 2017;37:497-511. DOI: 10.1016/j.iac.2017.03.00210.1016/j.iac.2017.03.002 Search in Google Scholar

2. Zanichelli A, Azin GM, Wu MA, Suffritti C, Maggioni L, Caccia S, et al. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency. J Allergy Clin Immunol Pract. 2017;5:1307-13. DOI: 10.1016/j.jaip.2016.12.03210.1016/j.jaip.2016.12.032 Search in Google Scholar

3. Wu MA, Castelli R. The Janus faces of acquired angioedema: C1-inhibitor deficiency, lym-phoproliferation and autoimmunity. Clin Chem Lab Med. 2016;54:207-14. DOI: 10.1515/cclm-2015-019510.1515/cclm-2015-0195 Search in Google Scholar

4. Pólai Z, Balla Z, Andrási N, Kőhalmi KV, Temesszentandrási G, Benedek S, et al. A follow-up survey of patients with acquired angioedema due to C1-inhibitor deficiency. J Intern Med. 2021;289:547-58. DOI: 10.1111/joim.1318210.1111/joim.13182 Search in Google Scholar

5. Schreiber AD, Zweiman B, Atkins P, Goldwein F, Pietra G, Atkinson B, et al. Acquired angi-oedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality. Blood. 1976;48:567-80. DOI: 10.1182/blood.V48.4.567.56710.1182/blood.V48.4.567.567 Search in Google Scholar

6. Frémeaux-Bacchi V, Guinnepain MT, Cacoub P, Dragon-Durey MA, Mouthon L, Blouin J, et al. Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2. Am J Med. 2002;113:194-9. DOI: 10.1016/S0002-9343(02)01124-510.1016/S0002-9343(02)01124-5 Search in Google Scholar

7. Bork K, Staubach-Renz P, Hardt J. Angioedema due to acquired C1-inhibitor deficiency: spec-trum and treatment with C1-inhibitor concentrate. Orphanet J Rare Dis. 2019;14:65. DOI: 10.1186/s13023-019-1043-310.1186/s13023-019-1043-3 Search in Google Scholar

8. Gajra A, Vajpayee N, Grethlein SJ. Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma. Am J Hematol. 2004;77:196-7. DOI: 10.1002/ajh.2016910.1002/ajh.20169 Search in Google Scholar

9. Takagi K, Yoshida A, Iwasaki H, Inoue H, Ueda T. Anti-CD20 antibody (Rituximab) therapy in a myasthenia gravis patient with follicular lymphoma. Ann Hematol. 2005;84:548-50. DOI: 10.1007/s00277-005-1050-410.1007/s00277-005-1050-4 Search in Google Scholar

10. Rezania K, Soliven B, Baron J, Lin H, Penumalli V, van Besien K. Myasthenia gravis, an auto-immune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature. Leuk Lymphoma. 2012;53:371-80. DOI: 10.3109/10428194.2011.61542610.3109/10428194.2011.615426 Search in Google Scholar

• Normality assessment, few paradigms and use cases

• Novel DCX pathogenic variant in a girl with subcortical band heterotopia

• Expression of serum soluble Klotho protein in patients with renal damage induced by anti-neutrophil cytoplasmic antibody-associated small-vessel vasculitis and influence on prognosis

• Expressions of TGF-β1 and VEGF in patients with acute myeloid leukemia and associations with prognosis

• Carbapenem resistance determinants in Klebsiella pneumoniae strains isolated from blood cultures-comparative analysis of molecular and phenotypic methods

• SPP1 is a biomarker of cervical cancer prognosis and involved in immune infiltration

• Elbow Septic Arthritis caused by Klebsiella pneumoniae in a Newborn - Case Report and Literature Review

• Downregulation of hsa-miR-4328 and target gene prediction in Acute Promyelocytic Leukemia

• Antibacterial Activity of Clove, Oregano, Thyme, Eucalyptus, and Tea Tree Essential Oils against Escherichia coli and Klebsiella pneumoniae strains

• Associations of serum vitamin D and Fok I polymorphism of receptor gene with unexplained recurrent spontaneous abortion